HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

JMB2002

SARS-CoV-2 neutralizing antibody

Also Known As:

JMB-2002

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Blood Proteins: 12459
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Neutralizing Antibodies: 9981
        JMB2002: 1
    - Immunoproteins: 43
      - Immunoglobulins: 30480
        Antibodies: 133716
        Neutralizing Antibodies: 9981
        JMB2002: 1
  - Globulins: 3062
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Neutralizing Antibodies: 9981
        JMB2002: 1

Experts

1.	Cao, Xiaodan: 1 article (01/2021)
2.	Chen, Xin: 1 article (01/2021)
3.	Chen, Zhen: 1 article (01/2021)
4.	Deng, Su-Jun: 1 article (01/2021)
5.	Gao, Ge: 1 article (01/2021)
6.	Gao, Li: 1 article (01/2021)
7.	Gu, Chunyin: 1 article (01/2021)
8.	Guan, Wuxiang: 1 article (01/2021)
9.	Guo, Haibing: 1 article (01/2021)
10.	Guo, Weiwei: 1 article (01/2021)

Related Diseases

1.	COVID-19 01/01/2021 - "Prophylactic and therapeutic countermeasure intervention of SARS-CoV-2 using JMB2002 would likely slow down the transmission of currently emerged SARS-CoV-2 variants and result in more efficient control of the COVID-19 pandemic."